Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Tags
NV354
Tag: NV354
Abliva’s CEO: ”Orphan drug designation is great validation”
15 December, 2023
FDA grants Abliva’s NV354 Orphan Drug Designation
19 April, 2023
Abliva recruits Vice President of Clinical Operations
10 February, 2023
Patient perspective in focus in Abliva’s phase II/III study
15 November, 2022
A new approach to mitochondrial diseases
10 August, 2022
Abliva’s NV354 targets fatal paediatric disease
27 October, 2021